首页> 外文会议>MEDINFO >KOTOBAKARI Study: Using Natural Language Processing of Patient Short Narratives to Detect Cancer Related Cognitive Impairment
【24h】

KOTOBAKARI Study: Using Natural Language Processing of Patient Short Narratives to Detect Cancer Related Cognitive Impairment

机译:Kotobakari研究:利用患者短篇叙事的自然语言处理来检测癌症相关的认知障碍

获取原文

摘要

Background: Recent reports of some studies have described that the cognitive function of cancer patients often declines by a phenomenon designated as cancer related cognitive impairment (CRCI). For patients’ decision-making, detecting CRCI is important. To do so, this study uses language-based CRCI screening to examine participants’ language ability. Objective: This study was conducted to ascertain whether a Natural Language Processing (NLP) based system can detect CRCI, or not. Materials and Methods: We obtained materials of two types from cancer patients (n = 116): (1) speech samples on three topics, and (2) cognitive function level test scores from Hasegawa’s Dementia Scale – Revised (HDS-R), a test used in Japan for dementia patients. The test is similar to the Mini-Mental State Examination. Results and Discussion: Cancer patients with lower HDS-R scores showed a significantly lower Type Token Ratio (TTR). Conclusion: This result demonstrates the feasibility of the proposed speech–language-based CRCI screening method.
机译:背景:最近关于一些研究的报道已经描述了癌症患者的认知功能常被指定为癌症相关认知障碍(CRCI)的现象。对于患者的决策,检测CRCI很重要。为此,本研究采用基于语言的CRCI筛选来检查参与者的语言能力。目的:进行该研究以确定基于自然语言处理(NLP)的系统是否可以检测CRCI。材料和方法:我们从癌症患者中获得两种类型的材料(n = 116):(1)三个主题的语音样本,(2)来自HALEGAWA的痴呆规模的认知功能水平测试评分 - 修订(HDS-R),a日本用于痴呆患者的测试。该测试类似于迷你精神状态检查。结果与讨论:HDS-R分数较低的癌症患者显示出显着较低的令牌比率(TTR)。结论:该结果展示了基于语音语言的CRCI筛选方法的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号